A549 |
Human lung carcinoma cell line |
CF |
Cystic fibrosis |
CFBE41o- |
Human bronchial epithelial cell line |
CFF |
Cystic Fibrosis Foundation |
CFTR |
Cystic fibrosis transmembrane conductance regulator |
CHEMS |
Cholesteryl hemisuccinate |
DCP |
Dichlorophenol |
DDAB |
Didecylmethylammonium bromide |
DMPC |
Dimyristoyl-sn-glycero-3-phosphocholine |
DMPG |
Dimyristoyl phosphatidyl-glycerol |
DNase |
Deoxyribonuclease |
DOPE |
Dioleoylphosphatidylethanolamine |
DOTAP |
Dioleoyloxy-3-trimethylammonium-propane |
DP |
Dry powder |
DPI |
Dry powder inhaler |
DPPC |
Dipalmitoyl phosphatidylcholine |
DSPC |
Distearoyl phosphatidylcholine |
eDNA |
Extracellular deoxyribonucleic acid |
FDA |
Food and Drug Administration |
EMA |
European Medicines Agency |
ESS |
Endoscopic sinus surgery |
H441 |
Human lung papillary adenocarcinoma cell line |
HSPC |
Hydrogenated soybean phosphatidylcholine |
J774 |
Murine macrophage cell line |
LF |
Liquid formulation |
N/A |
not available |
PC |
Phosphatidylcholine |
PEG |
Poly (ethylene glycol) |
PLGA |
Poly (lactic-co-glycolic) acid |
PVA |
Polyvinyl alcohol |
TIS |
Tobramycin inhalation solution |
TIP |
Tobramycin inhalation powder |